Characterization of the Small Bowel Microbiome Reveals Different Profiles in Human Subjects Who Are Overweight or Have Obesity
INTRODUCTION:Gut microbiome changes are linked to obesity, but findings are based on stool data. In this article, we analyzed the duodenal microbiome and serum biomarkers in subjects with normal weight, overweight, and obesity.METHODS:Duodenal aspirates and serum samples were obtained from subjects...
Saved in:
Published in | The American journal of gastroenterology Vol. 119; no. 6; pp. 1141 - 1153 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Philadelphia, PA
Wolters Kluwer
01.06.2024
Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | INTRODUCTION:Gut microbiome changes are linked to obesity, but findings are based on stool data. In this article, we analyzed the duodenal microbiome and serum biomarkers in subjects with normal weight, overweight, and obesity.METHODS:Duodenal aspirates and serum samples were obtained from subjects undergoing standard-of-care esophagogastroduodenoscopy without colon preparation. Aspirate DNAs were analyzed by 16S rRNA and shotgun sequencing. Predicted microbial metabolic functions and serum levels of metabolic and inflammatory biomarkers were also assessed.RESULTS:Subjects with normal weight (N = 105), overweight (N = 67), and obesity (N = 42) were identified. Overweight-specific duodenal microbial features include lower relative abundance (RA) of Bifidobacterium species and Escherichia coli strain K-12 and higher Lactobacillus intestinalis, L. johnsonii, and Prevotella loescheii RA. Obesity-specific features include higher Lactobacillus gasseri RA and lower L. reuteri (subspecies rodentium), Alloprevotella rava, and Leptotrichia spp RA. Escalation features (progressive changes from normal weight through obesity) include decreasing Bacteroides pyogenes, Staphylococcus hominis, and unknown Faecalibacterium species RA, increasing RA of unknown Lactobacillus and Mycobacterium species, and decreasing microbial potential for biogenic amines metabolism. De-escalation features (direction of change altered in normal to overweight and overweight to obesity) include Lactobacillus acidophilus, L. hominis, L. iners, and Bifidobacterium dentium. An unknown Lactobacillus species is associated with type IIa dyslipidemia and overweight, whereas Alloprevotella rava is associated with type IIb and IV dyslipidemias.DISCUSSION:Direct analysis of the duodenal microbiome has identified key genera associated with overweight and obesity, including some previously identified in stool, e.g., Bifidobacterium and Lactobacillus. Specific species and strains exhibit differing associations with overweight and obesity, including escalation and de-escalation features that may represent targets for future study and therapeutics. |
---|---|
AbstractList | Gut microbiome changes are linked to obesity, but findings are based on stool data. In this article, we analyzed the duodenal microbiome and serum biomarkers in subjects with normal weight, overweight, and obesity.
Duodenal aspirates and serum samples were obtained from subjects undergoing standard-of-care esophagogastroduodenoscopy without colon preparation. Aspirate DNAs were analyzed by 16S rRNA and shotgun sequencing. Predicted microbial metabolic functions and serum levels of metabolic and inflammatory biomarkers were also assessed.
Subjects with normal weight (N = 105), overweight (N = 67), and obesity (N = 42) were identified. Overweight-specific duodenal microbial features include lower relative abundance (RA) of Bifidobacterium species and Escherichia coli strain K-12 and higher Lactobacillus intestinalis , L. johnsonii , and Prevotella loescheii RA. Obesity-specific features include higher Lactobacillus gasseri RA and lower L. reuteri (subspecies rodentium ), Alloprevotella rava , and Leptotrichia spp RA. Escalation features (progressive changes from normal weight through obesity) include decreasing Bacteroides pyogenes , Staphylococcus hominis , and unknown Faecalibacterium species RA, increasing RA of unknown Lactobacillus and Mycobacterium species, and decreasing microbial potential for biogenic amines metabolism. De-escalation features (direction of change altered in normal to overweight and overweight to obesity) include Lactobacillus acidophilus , L. hominis , L. iners , and Bifidobacterium dentium . An unknown Lactobacillus species is associated with type IIa dyslipidemia and overweight, whereas Alloprevotella rava is associated with type IIb and IV dyslipidemias.
Direct analysis of the duodenal microbiome has identified key genera associated with overweight and obesity, including some previously identified in stool, e.g., Bifidobacterium and Lactobacillus . Specific species and strains exhibit differing associations with overweight and obesity, including escalation and de-escalation features that may represent targets for future study and therapeutics. Gut microbiome changes are linked to obesity, but findings are based on stool data. In this article, we analyzed the duodenal microbiome and serum biomarkers in subjects with normal weight, overweight, and obesity.INTRODUCTIONGut microbiome changes are linked to obesity, but findings are based on stool data. In this article, we analyzed the duodenal microbiome and serum biomarkers in subjects with normal weight, overweight, and obesity.Duodenal aspirates and serum samples were obtained from subjects undergoing standard-of-care esophagogastroduodenoscopy without colon preparation. Aspirate DNAs were analyzed by 16S rRNA and shotgun sequencing. Predicted microbial metabolic functions and serum levels of metabolic and inflammatory biomarkers were also assessed.METHODSDuodenal aspirates and serum samples were obtained from subjects undergoing standard-of-care esophagogastroduodenoscopy without colon preparation. Aspirate DNAs were analyzed by 16S rRNA and shotgun sequencing. Predicted microbial metabolic functions and serum levels of metabolic and inflammatory biomarkers were also assessed.Subjects with normal weight (N = 105), overweight (N = 67), and obesity (N = 42) were identified. Overweight-specific duodenal microbial features include lower relative abundance (RA) of Bifidobacterium species and Escherichia coli strain K-12 and higher Lactobacillus intestinalis , L. johnsonii , and Prevotella loescheii RA. Obesity-specific features include higher Lactobacillus gasseri RA and lower L. reuteri (subspecies rodentium ), Alloprevotella rava , and Leptotrichia spp RA. Escalation features (progressive changes from normal weight through obesity) include decreasing Bacteroides pyogenes , Staphylococcus hominis , and unknown Faecalibacterium species RA, increasing RA of unknown Lactobacillus and Mycobacterium species, and decreasing microbial potential for biogenic amines metabolism. De-escalation features (direction of change altered in normal to overweight and overweight to obesity) include Lactobacillus acidophilus , L. hominis , L. iners , and Bifidobacterium dentium . An unknown Lactobacillus species is associated with type IIa dyslipidemia and overweight, whereas Alloprevotella rava is associated with type IIb and IV dyslipidemias.RESULTSSubjects with normal weight (N = 105), overweight (N = 67), and obesity (N = 42) were identified. Overweight-specific duodenal microbial features include lower relative abundance (RA) of Bifidobacterium species and Escherichia coli strain K-12 and higher Lactobacillus intestinalis , L. johnsonii , and Prevotella loescheii RA. Obesity-specific features include higher Lactobacillus gasseri RA and lower L. reuteri (subspecies rodentium ), Alloprevotella rava , and Leptotrichia spp RA. Escalation features (progressive changes from normal weight through obesity) include decreasing Bacteroides pyogenes , Staphylococcus hominis , and unknown Faecalibacterium species RA, increasing RA of unknown Lactobacillus and Mycobacterium species, and decreasing microbial potential for biogenic amines metabolism. De-escalation features (direction of change altered in normal to overweight and overweight to obesity) include Lactobacillus acidophilus , L. hominis , L. iners , and Bifidobacterium dentium . An unknown Lactobacillus species is associated with type IIa dyslipidemia and overweight, whereas Alloprevotella rava is associated with type IIb and IV dyslipidemias.Direct analysis of the duodenal microbiome has identified key genera associated with overweight and obesity, including some previously identified in stool, e.g., Bifidobacterium and Lactobacillus . Specific species and strains exhibit differing associations with overweight and obesity, including escalation and de-escalation features that may represent targets for future study and therapeutics.DISCUSSIONDirect analysis of the duodenal microbiome has identified key genera associated with overweight and obesity, including some previously identified in stool, e.g., Bifidobacterium and Lactobacillus . Specific species and strains exhibit differing associations with overweight and obesity, including escalation and de-escalation features that may represent targets for future study and therapeutics. INTRODUCTION:Gut microbiome changes are linked to obesity, but findings are based on stool data. In this article, we analyzed the duodenal microbiome and serum biomarkers in subjects with normal weight, overweight, and obesity.METHODS:Duodenal aspirates and serum samples were obtained from subjects undergoing standard-of-care esophagogastroduodenoscopy without colon preparation. Aspirate DNAs were analyzed by 16S rRNA and shotgun sequencing. Predicted microbial metabolic functions and serum levels of metabolic and inflammatory biomarkers were also assessed.RESULTS:Subjects with normal weight (N = 105), overweight (N = 67), and obesity (N = 42) were identified. Overweight-specific duodenal microbial features include lower relative abundance (RA) of Bifidobacterium species and Escherichia coli strain K-12 and higher Lactobacillus intestinalis, L. johnsonii, and Prevotella loescheii RA. Obesity-specific features include higher Lactobacillus gasseri RA and lower L. reuteri (subspecies rodentium), Alloprevotella rava, and Leptotrichia spp RA. Escalation features (progressive changes from normal weight through obesity) include decreasing Bacteroides pyogenes, Staphylococcus hominis, and unknown Faecalibacterium species RA, increasing RA of unknown Lactobacillus and Mycobacterium species, and decreasing microbial potential for biogenic amines metabolism. De-escalation features (direction of change altered in normal to overweight and overweight to obesity) include Lactobacillus acidophilus, L. hominis, L. iners, and Bifidobacterium dentium. An unknown Lactobacillus species is associated with type IIa dyslipidemia and overweight, whereas Alloprevotella rava is associated with type IIb and IV dyslipidemias.DISCUSSION:Direct analysis of the duodenal microbiome has identified key genera associated with overweight and obesity, including some previously identified in stool, e.g., Bifidobacterium and Lactobacillus. Specific species and strains exhibit differing associations with overweight and obesity, including escalation and de-escalation features that may represent targets for future study and therapeutics. INTRODUCTION:Gut microbiome changes are linked to obesity, but findings are based on stool data. In this article, we analyzed the duodenal microbiome and serum biomarkers in subjects with normal weight, overweight, and obesity.METHODS:Duodenal aspirates and serum samples were obtained from subjects undergoing standard-of-care esophagogastroduodenoscopy without colon preparation. Aspirate DNAs were analyzed by 16S rRNA and shotgun sequencing. Predicted microbial metabolic functions and serum levels of metabolic and inflammatory biomarkers were also assessed.RESULTS:Subjects with normal weight (N = 105), overweight (N = 67), and obesity (N = 42) were identified. Overweight-specific duodenal microbial features include lower relative abundance (RA) of Bifidobacterium species and Escherichia coli strain K-12 and higher Lactobacillus intestinalis, L. johnsonii, and Prevotella loescheii RA. Obesity-specific features include higher Lactobacillus gasseri RA and lower L. reuteri (subspecies rodentium), Alloprevotella rava, and Leptotrichia spp RA. Escalation features (progressive changes from normal weight through obesity) include decreasing Bacteroides pyogenes, Staphylococcus hominis, and unknown Faecalibacterium species RA, increasing RA of unknown Lactobacillus and Mycobacterium species, and decreasing microbial potential for biogenic amines metabolism. De-escalation features (direction of change altered in normal to overweight and overweight to obesity) include Lactobacillus acidophilus, L. hominis, L. iners, and Bifidobacterium dentium. An unknown Lactobacillus species is associated with type IIa dyslipidemia and overweight, whereas Alloprevotella rava is associated with type IIb and IV dyslipidemias.DISCUSSION:Direct analysis of the duodenal microbiome has identified key genera associated with overweight and obesity, including some previously identified in stool, e.g., Bifidobacterium and Lactobacillus. Specific species and strains exhibit differing associations with overweight and obesity, including escalation and de-escalation features that may represent targets for future study and therapeutics. abstract-type="graphical"> |
Author | Pimentel, Mark Morales, Walter Barlow, Gillian M. Weitsman, Stacy Hosseini, Ava Rezaie, Ali Parodi, Gonzalo Leite, Gabriela Cohrs, Daniel Mathur, Ruchi Rashid, Mohamad |
Author_xml | – sequence: 1 givenname: Gabriela orcidid: 0000-0001-5772-7735 surname: Leite fullname: Leite, Gabriela email: Gabriela.leite@cshs.org organization: Medically Associated Science and Technology (MAST) Program, Cedars-Sinai, Los Angeles, California – sequence: 2 givenname: Gillian M. orcidid: 0000-0002-0487-048X surname: Barlow fullname: Barlow, Gillian M. email: gillian.barlow@cshs.org organization: Medically Associated Science and Technology (MAST) Program, Cedars-Sinai, Los Angeles, California – sequence: 3 givenname: Mohamad orcidid: 0000-0002-1256-9478 surname: Rashid fullname: Rashid, Mohamad email: mohamad.rashid@cshs.org organization: Medically Associated Science and Technology (MAST) Program, Cedars-Sinai, Los Angeles, California – sequence: 4 givenname: Ava orcidid: 0000-0002-1979-3034 surname: Hosseini fullname: Hosseini, Ava email: Ava.Hosseini@cshs.org organization: Medically Associated Science and Technology (MAST) Program, Cedars-Sinai, Los Angeles, California – sequence: 5 givenname: Daniel orcidid: 0000-0002-9595-4856 surname: Cohrs fullname: Cohrs, Daniel email: dcohrs3@gmail.com organization: Medically Associated Science and Technology (MAST) Program, Cedars-Sinai, Los Angeles, California – sequence: 6 givenname: Gonzalo surname: Parodi fullname: Parodi, Gonzalo email: Gonzalo.Parodi@cshs.org organization: Medically Associated Science and Technology (MAST) Program, Cedars-Sinai, Los Angeles, California – sequence: 7 givenname: Walter surname: Morales fullname: Morales, Walter email: Walter.Morales@cshs.org organization: Medically Associated Science and Technology (MAST) Program, Cedars-Sinai, Los Angeles, California – sequence: 8 givenname: Stacy orcidid: 0009-0006-7069-701X surname: Weitsman fullname: Weitsman, Stacy email: Stacy.weitsman@cshs.org organization: Medically Associated Science and Technology (MAST) Program, Cedars-Sinai, Los Angeles, California – sequence: 9 givenname: Ali orcidid: 0000-0002-0106-372X surname: Rezaie fullname: Rezaie, Ali email: ali.rezaie@cshs.org organization: Karsh Division of Gastroenterology and Hepatology, Department of Medicine, Cedars-Sinai, Los Angeles, California – sequence: 10 givenname: Mark orcidid: 0000-0002-0619-5115 surname: Pimentel fullname: Pimentel, Mark email: pimentelm@cshs.org organization: Karsh Division of Gastroenterology and Hepatology, Department of Medicine, Cedars-Sinai, Los Angeles, California – sequence: 11 givenname: Ruchi orcidid: 0000-0003-1053-6557 surname: Mathur fullname: Mathur, Ruchi organization: Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Cedars-Sinai, Los Angeles, California |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38578969$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU1vEzEQhi1URNPCTwBZ4sJli792HYtTCS1BKiqiII4rrzPuOnjXxfYmKgd-O6YpCOXSuYw0et7RaJ4jdDCGERB6TskJFZyo13p9fUL-KyYVeYRmtJasIkzQAzT7M60Uk-QQHaW0JoTWTNZP0CGf13KuGjVDvxa9jtpkiO6nzi6MOFice8BXg_Yevw1b8PijMzF0LgyAP8MGtE_4nbMWIowZf4rBOg8JuxEvp0GP-Grq1mBywt_6gE8j4MsNxC246z7jEPFSb8qog-Ty7VP02JZ18Oy-H6Ov52dfFsvq4vL9h8XpRWUEF6RqtBW1tivZSUaoscAMEZR3zKgVtRSsrnkjJShtuVJzYjppiQJVc0ObjhJ-jF7t9t7E8GOClNvBJQPe6xHClFpOuGBCNfOmoC_30HWY4liuK1QjiJKUskK9uKemboBVexPdoONt-_ezBah3QHldShHsP4SS9s5gWwy2-wZL7s1ezrh8ZyZH7fyDabVLb4MvTtN3P20htn1xlvsHsr8BlHeyEA |
CitedBy_id | crossref_primary_10_14309_ajg_0000000000002855 crossref_primary_10_14309_ajg_0000000000003071 crossref_primary_10_1080_19490976_2024_2405547 crossref_primary_10_1039_D4FO03049D crossref_primary_10_3390_brainsci14080807 crossref_primary_10_1097_MD_0000000000041617 |
Cites_doi | 10.1038/ismej.2009.112 10.1016/S2213-8587(18)30288-2 10.1038/ijo.2008.155 10.1016/j.copbio.2014.09.005 10.1038/s41598-022-05723-9 10.1007/s10620-020-06173-x 10.1016/j.jnutbio.2018.10.003 10.1038/nature05414 10.1155/2018/2037838 10.1097/GME.0000000000001917 10.1371/journal.pone.0009085 10.1186/s40168-021-01101-1 10.1016/j.celrep.2021.109765 10.1016/j.jcmgh.2019.07.006 10.1002/mnfr.202100639 10.1016/j.ebiom.2020.102766 10.3389/fnut.2019.00024 10.1038/nature11234 10.4093/dmj.2015.39.3.198 10.1038/4441022a 10.1136/gutjnl-2021-326158 10.1056/NEJMra1514009 10.1016/j.metabol.2023.155712 10.1038/nature12506 10.1038/s41418-022-01062-4 10.1371/journal.pcbi.1003531 10.1016/j.micpath.2012.05.007 10.1186/s40168-021-01162-2 10.4082/kjfm.2013.34.2.80 10.3390/jcm9020369 10.1111/j.1462-2920.2009.01941.x 10.1186/s40168-017-0237-y 10.1186/s12866-019-1617-1 10.1038/s41598-023-37720-x 10.1371/journal.pone.0178868 10.1016/j.cgh.2023.06.001 10.1186/s40168-022-01374-0 10.1056/NEJMoa1614362 10.1038/s41591-022-01688-4 10.1038/oby.2009.167 10.1016/j.pbj.2016.03.005 10.1038/nutd.2014.6 10.1038/ijo.2017.161 10.1016/j.soard.2020.04.008 10.1080/19490976.2023.2172671 10.1371/journal.pone.0137784 10.3390/microorganisms8111811 10.1093/nar/gks808 10.1016/0002-9149(90)91247-4 10.1126/scitranslmed.3000322 |
ContentType | Journal Article |
Copyright | Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology – notice: Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. – notice: Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 |
DOI | 10.14309/ajg.0000000000002790 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest One Academic Middle East (New) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1572-0241 |
EndPage | 1153 |
ExternalDocumentID | 38578969 10_14309_ajg_0000000000002790 AJG-23-2490 |
Genre | research-article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Monica Lester Charitable Trust – fundername: Elias, Genevieve, and Georgianna Atol Charitable Trust |
GroupedDBID | --- --K -Q- .55 .GJ 0R~ 123 1B1 1OC 23M 31~ 36B 39C 3O- 4.4 4G. 53G 5RE 5VS 6J9 70F 7X7 88E 8FI 8FJ 8GM AAAAV AAEDT AAGIX AAHPQ AAIQE AAJCS AALRI AAMOA AAQFI AAQKA AAQQT AAQXK AASCR AASXQ AAXUO ABASU ABAWZ ABDIG ABJNI ABLJU ABOCM ABPXF ABUWG ABVCZ ABWVN ABXYN ABZZY ACGFO ACGFS ACILI ACKTT ACLDA ACNWC ACOAL ACRPL ACXJB ACXQS ACZKN ADBBV ADFRT ADGGA ADHPY ADMUD ADNKB ADNMO ADSXY AEBDS AEETU AENEX AEXYK AFBFQ AFBPY AFDTB AFEBI AFEXH AFFNX AFKRA AFNMH AFUWQ AGAYW AGQPQ AHMBA AHOMT AHQNM AHQVU AHSBF AHVBC AI. AINUH AJAOE AJCLO AJIOK AJNWD AJRNO AJZMW AKCTQ AKRWK AKULP ALIPV ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BENPR BPHCQ BVXVI BYPQX C45 CAG CCPQU COF CS3 DIWNM EBS EE. EEVPB EJD EMB EMOBN ERAAH F5P FCALG FDB FDQFY FEDTE FGOYB FYUFA GNXGY GQDEL HLJTE HMCUK HVGLF HZ~ IHE IKREB IKYAY IPNFZ JSO LH4 LW6 M1P M41 N4W NQ- O9- ODMTH OPUJH OVD OVDNE P0W P2P PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO R2- RIG RLZ RNT RNTTT ROL RPZ SEW SJN SSZ SV3 TEORI TSPGW UDS UKHRP VH1 X7M XIF XPP ZGI ZXP ZZMQN AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK K9. PKEHL PQEST PQUKI 7X8 |
ID | FETCH-LOGICAL-c4340-6af45afd7b7201cfe2c0413b2c9d1f1efa53677e9af39980cb7f09e953c16b103 |
IEDL.DBID | 7X7 |
ISSN | 0002-9270 1572-0241 |
IngestDate | Mon Jul 21 09:46:28 EDT 2025 Sat Aug 23 12:23:51 EDT 2025 Mon Jul 21 06:05:39 EDT 2025 Thu Aug 07 06:52:30 EDT 2025 Thu Apr 24 22:52:25 EDT 2025 Mon Aug 04 20:40:26 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | biogenic amines metabolism small intestinal microbiome dyslipidemias overweight obesity |
Language | English |
License | http://creativecommons.org/licenses/by-nc-nd/4.0 Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4340-6af45afd7b7201cfe2c0413b2c9d1f1efa53677e9af39980cb7f09e953c16b103 |
Notes | Correspondence: Ruchi Mathur, MD. E-mail: ruchi.mathur@cshs.org.SUPPLEMENTARY MATERIAL accompanies this paper at http://links.lww.com/AJG/D239. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0009-0006-7069-701X 0000-0002-0106-372X 0000-0002-1979-3034 0000-0002-0487-048X 0000-0002-1256-9478 0000-0002-9595-4856 0000-0001-5772-7735 0000-0002-0619-5115 0000-0003-1053-6557 0000-0002-0106-372 0009-0006-7069-701 0000-0002-0487-048 |
OpenAccessLink | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&DO=10.14309/ajg.0000000000002790 |
PMID | 38578969 |
PQID | 3064097112 |
PQPubID | 2041977 |
PageCount | 13 |
ParticipantIDs | proquest_miscellaneous_3034249686 proquest_journals_3064097112 pubmed_primary_38578969 crossref_primary_10_14309_ajg_0000000000002790 crossref_citationtrail_10_14309_ajg_0000000000002790 wolterskluwer_health_10_14309_ajg_0000000000002790 |
PublicationCentury | 2000 |
PublicationDate | 2024-June 2024-06-00 2024-06-01 20240601 |
PublicationDateYYYYMMDD | 2024-06-01 |
PublicationDate_xml | – month: 06 year: 2024 text: 2024-June |
PublicationDecade | 2020 |
PublicationPlace | Philadelphia, PA |
PublicationPlace_xml | – name: Philadelphia, PA – name: United States – name: New York |
PublicationTitle | The American journal of gastroenterology |
PublicationTitleAbbrev | Am J Gastroenterol |
PublicationTitleAlternate | Am J Gastroenterol |
PublicationYear | 2024 |
Publisher | Wolters Kluwer Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins |
Publisher_xml | – name: Wolters Kluwer – name: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins |
References | Heymsfield, Wadden (R7) 2017; 376 Barlow, Lin, Mathur, Bagchi, Nair (R36) 2018 Hur, Lee (R12) 2015; 39 Gutierrez-Repiso, Moreno-Indias, Martin-Nunez (R52) 2020; 16 Fact Sheet-Obesity and Overweight. World Health Organization: Geneva, Switzerland, 2020. Centers for Disease Control and Prevention. Overweight & Obesity. 2022. (https://www.cdc.gov/obesity/index.html). Accessed July 12, 2023. LaRosa (R29) 1990; 65 Darra, Singh, Jena (R51) 2023; 13 Ley, Turnbaugh, Klein (R15) 2006; 444 Leite, Morales, Weitsman (R22) 2019; 19 Larabi, Masson, Bäumler (R44) 2023; 15 Larsen, Vogensen, van den Berg (R13) 2010; 5 Belizario, Faintuch, Garay-Malpartida (R10) 2018; 2018 Le Chatelier, Nielsen, Qin (R19) 2013; 500 Leser, Mølbak (R21) 2009; 11 Million, Angelakis, Paul (R45) 2012; 53 Leite, Rezaie, Mathur (R27) 2024; 22 (R9) 2012; 486 Angelakis, Armougom, Carriere (R56) 2015; 10 Duncan, Lobley, Holtrop (R18) 2008; 32 McMurdie, Holmes (R31) 2014; 10 Guzior, Quinn (R42) 2021; 9 Kastl, Terry, Wu (R37) 2020; 9 Hildebrandt, Ibrahim, Peltzer (R48) 2023; 30 Leite, Weitsman, Parodi (R24) 2020; 65 Ramos-Molina, Queipo-Ortuno, Lambertos (R49) 2019; 6 Afshin, Forouzanfar (R6) 2017; 377 Turnbaugh, Ley, Mahowald (R14) 2006; 444 Schwiertz, Taras, Schafer (R16) 2010; 18 Wu, Zhang, Ren (R35) 2017; 12 Weiss, Xu, Peddada (R32) 2017; 5 Kim, Yoon, Park (R46) 2022; 10 Sroka-Oleksiak, Mlodzinska, Bulanda (R54) 2020; 9 Centers for Disease Control and Prevention. Adult Obesity Facts. 2020. (https://www.cdc.gov/obesity/data/adult.html). Accessed July 12, 2023. Leite, Pimentel, Barlow (R25) 2021; 36 El Aidy, van den Bogert, Kleerebezem (R20) 2015; 32 Klindworth, Pruesse, Schweer (R30) 2013; 41 Leite, Barlow, Parodi (R26) 2022; 29 Villmones, Svanevik, Ulvestad (R53) 2022; 12 National Cancer Institute. Obesity and Cancer. 2017. (https://www.cancer.gov/about-cancer/causes-prevention/risk/obesity/obesity-fact-sheet). Accessed July 12, 2023. Shanahan, Kang, Staudacher (R57) 2023; 72 Zhang, Zhang, Wang (R17) 2010; 4 Crovesy, Ostrowski, Ferreira (R41) 2017; 41 Ma, Zheng, Ni (R47) 2022; 66 Centers for Disease Control and Prevention. Adult Obesity Causes & Consequences. 2021. (https://www.cdc.gov/obesity/adult/causes.html). Accessed July 12, 2023. Fromentin, Forslund, Chechi (R34) 2022; 28 Granata, Nardelli, D'Argenio (R55) 2020; 8 Bhaskaran, Dos-Santos-Silva, Leon (R8) 2018; 6 (R28) 2021; 44 Barlow, Leite, Romano (R23) 2021; 9 Steinbach, Masi, Ribeiro (R50) 2024; 150 Rouxinol-Dias, Pinto, Janeiro (R38) 2016; 1 Wei, Huang, Zhao (R43) 2020; 55 Turnbaugh, Ridaura, Faith (R33) 2009; 1 Drissi, Merhej, Angelakis (R39) 2014; 4 Sharma, Tripathi (R11) 2019; 63 Jung, Lee, Kang (R40) 2013; 34 Zhang (R17-20250804) 2010; 4 Leite (R25-20250804) 2021; 36 LaRosa (R29-20250804) 1990; 65 Steinbach (R50-20250804) 2024; 150 Million (R45-20250804) 2012; 53 McMurdie (R31-20250804) 2014; 10 (R9-20250804) 2012; 486 Angelakis (R56-20250804) 2015; 10 Granata (R55-20250804) 2020; 8 Kim (R46-20250804) 2022; 10 Crovesy (R41-20250804) 2017; 41 Hur (R12-20250804) 2015; 39 Le Chatelier (R19-20250804) 2013; 500 Ley (R15-20250804) 2006; 444 Ramos-Molina (R49-20250804) 2019; 6 Leite (R26-20250804) 2022; 29 Wu (R35-20250804) 2017; 12 Heymsfield (R7-20250804) 2017; 376 Fromentin (R34-20250804) 2022; 28 Wei (R43-20250804) 2020; 55 Sroka-Oleksiak (R54-20250804) 2020; 9 Guzior (R42-20250804) 2021; 9 Rouxinol-Dias (R38-20250804) 2016; 1 Larsen (R13-20250804) 2010; 5 Leite (R22-20250804) 2019; 19 Larabi (R44-20250804) 2023; 15 Jung (R40-20250804) 2013; 34 Hildebrandt (R48-20250804) 2023; 30 Darra (R51-20250804) 2023; 13 (R28-20250804) 2021; 44 Schwiertz (R16-20250804) 2010; 18 Kastl (R37-20250804) 2020; 9 Afshin (R6-20250804) 2017; 377 Barlow (R23-20250804) 2021; 9 El Aidy (R20-20250804) 2015; 32 Leite (R27-20250804) 2024; 22 Leite (R24-20250804) 2020; 65 Turnbaugh (R33-20250804) 2009; 1 Bhaskaran (R8-20250804) 2018; 6 Villmones (R53-20250804) 2022; 12 Duncan (R18-20250804) 2008; 32 Gutierrez-Repiso (R52-20250804) 2020; 16 Belizario (R10-20250804) 2018; 2018 Drissi (R39-20250804) 2014; 4 Klindworth (R30-20250804) 2013; 41 Leser (R21-20250804) 2009; 11 Sharma (R11-20250804) 2019; 63 Shanahan (R57-20250804) 2023; 72 Weiss (R32-20250804) 2017; 5 Turnbaugh (R14-20250804) 2006; 444 Ma (R47-20250804) 2022; 66 |
References_xml | – volume: 376 start-page: 254 issue: 3 year: 2017 end-page: 66 ident: R7 article-title: Mechanisms, pathophysiology, and management of obesity publication-title: N Engl J Med – volume: 444 start-page: 1022 issue: 7122 year: 2006 end-page: 3 ident: R15 article-title: Microbial ecology: Human gut microbes associated with obesity publication-title: Nature – volume: 39 start-page: 198 issue: 3 year: 2015 end-page: 203 ident: R12 article-title: Gut microbiota and metabolic disorders publication-title: Diabetes Metab J – volume: 4 start-page: 232 issue: 2 year: 2010 end-page: 41 ident: R17 article-title: Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice publication-title: ISME J – volume: 9 start-page: 214 issue: 1 year: 2021 ident: R23 article-title: Quantitative sequencing clarifies the role of disruptor taxa, oral microbiota, and strict anaerobes in the human small-intestine microbiome publication-title: Microbiome – volume: 444 start-page: 1027 issue: 7122 year: 2006 end-page: 31 ident: R14 article-title: An obesity-associated gut microbiome with increased capacity for energy harvest publication-title: Nature – volume: 16 start-page: 1575 issue: 10 year: 2020 end-page: 85 ident: R52 article-title: Mucosa-associated microbiota in the jejunum of patients with morbid obesity: Alterations in states of insulin resistance and metformin treatment publication-title: Surg Obes Relat Dis – volume: 29 start-page: 264 issue: 3 year: 2022 end-page: 75 ident: R26 article-title: Duodenal microbiome changes in postmenopausal women: Effects of hormone therapy and implications for cardiovascular risk publication-title: Menopause – volume: 30 start-page: 279 issue: 2 year: 2023 end-page: 92 ident: R48 article-title: Cell death and inflammation during obesity: "Know my methods, WAT(son)" publication-title: Cell Death Different – volume: 486 start-page: 207 issue: 7402 year: 2012 end-page: 14 ident: R9 article-title: Structure, function and diversity of the healthy human microbiome publication-title: Nature – volume: 5 start-page: e9085 year: 2010 ident: R13 article-title: Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults publication-title: PLoS One – volume: 41 start-page: e1 issue: 1 year: 2013 ident: R30 article-title: Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies publication-title: Nucleic Acids Res – volume: 4 start-page: e109 issue: 2 year: 2014 ident: R39 article-title: Comparative genomics analysis of Lactobacillus species associated with weight gain or weight protection publication-title: Nutr Diabetes – volume: 41 start-page: 1607 issue: 11 year: 2017 end-page: 14 ident: R41 article-title: Effect of Lactobacillus on body weight and body fat in overweight subjects: A systematic review of randomized controlled clinical trials publication-title: Int J Obes – volume: 9 start-page: 369 year: 2020 ident: R54 article-title: Metagenomic analysis of duodenal microbiota reveals a potential biomarker of dysbiosis in the course of obesity and type 2 diabetes: A pilot study publication-title: J Clin Med – volume: 12 start-page: e0178868 issue: 6 year: 2017 ident: R35 article-title: Effect of probiotic Lactobacillus on lipid profile: A systematic review and meta-analysis of randomized, controlled trials publication-title: PLoS One – volume: 66 start-page: e2100639 issue: 3 year: 2022 ident: R47 article-title: Bifidobacterium animalis subsp. lactis lkm512 attenuates obesity-associated inflammation and insulin resistance through the modification of gut microbiota in high-fat diet-induced obese mice publication-title: Mol Nutr Food Res – volume: 13 start-page: 11038 issue: 1 year: 2023 ident: R51 article-title: Hyperglycemia is associated with duodenal dysbiosis and altered duodenal microenvironment publication-title: Sci Rep – volume: 12 start-page: 1682 issue: 1 year: 2022 ident: R53 article-title: Investigating the human jejunal microbiota publication-title: Sci Rep – reference: Fact Sheet-Obesity and Overweight. World Health Organization: Geneva, Switzerland, 2020. – volume: 65 start-page: 7f issue: 12 year: 1990 end-page: 10f ident: R29 article-title: At what levels of total low- or high-density lipoprotein cholesterol should diet/drug therapy be initiated? United States guidelines publication-title: Am J Cardiol – start-page: 65 year: 2018 end-page: 91 ident: R36 article-title: An overview of the roles of the gut microbiome in obesity and diabetes publication-title: Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome – volume: 1 start-page: 6ra14 issue: 6 year: 2009 ident: R33 article-title: The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice publication-title: Sci Transl Med – volume: 63 start-page: 101 year: 2019 end-page: 8 ident: R11 article-title: Gut microbiome and type 2 diabetes: Where we are and where to go? publication-title: J Nutr Biochem – volume: 53 start-page: 100 issue: 2 year: 2012 end-page: 8 ident: R45 article-title: Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals publication-title: Microb Pathog – volume: 18 start-page: 190 issue: 1 year: 2010 end-page: 5 ident: R16 article-title: Microbiota and SCFA in lean and overweight healthy subjects publication-title: Obesity (Silver Spring) – volume: 9 start-page: 33 issue: 1 year: 2020 end-page: 45 ident: R37 article-title: The structure and function of the human small intestinal microbiota: Current understanding and future directions publication-title: Cell Mol Gastroenterol Hepatol – volume: 15 start-page: 2172671 issue: 1 year: 2023 ident: R44 article-title: Bile acids as modulators of gut microbiota composition and function publication-title: Gut Microbes – volume: 65 start-page: 2595 issue: 9 year: 2020 end-page: 604 ident: R24 article-title: Mapping the segmental microbiomes in the human small bowel in comparison with stool: A REIMAGINE study publication-title: Dig Dis Sci – volume: 36 start-page: 109765 issue: 13 year: 2021 ident: R25 article-title: Age and the aging process significantly alter the small bowel microbiome publication-title: Cell Rep – volume: 22 start-page: 259 issue: 2 year: 2024 end-page: 70 ident: R27 article-title: Defining small intestinal bacterial overgrowth by culture and high throughput sequencing publication-title: Clin Gastroenterol Hepatol – volume: 5 start-page: 27 issue: 1 year: 2017 ident: R32 article-title: Normalization and microbial differential abundance strategies depend upon data characteristics publication-title: Microbiome – volume: 44 start-page: S15 issue: Suppl 1 year: 2021 end-page: 33 ident: R28 article-title: 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2021 publication-title: Diabetes Care – volume: 6 start-page: 24 year: 2019 ident: R49 article-title: Dietary and gut microbiota polyamines in obesity- and age-related diseases publication-title: Front Nutr – volume: 2018 start-page: 2037838 year: 2018 ident: R10 article-title: Gut microbiome dysbiosis and immunometabolism: New frontiers for treatment of metabolic diseases publication-title: Mediators Inflamm – volume: 10 start-page: e0137784 issue: 9 year: 2015 ident: R56 article-title: A metagenomic investigation of the duodenal microbiota reveals links with obesity publication-title: PLoS One – volume: 72 start-page: 929 issue: 5 year: 2023 end-page: 38 ident: R57 article-title: Alterations to the duodenal microbiota are linked to gastric emptying and symptoms in functional dyspepsia publication-title: Gut – reference: Centers for Disease Control and Prevention. Adult Obesity Causes & Consequences. 2021. (https://www.cdc.gov/obesity/adult/causes.html). Accessed July 12, 2023. – volume: 1 start-page: 12 year: 2016 end-page: 24 ident: R38 article-title: Probiotics for the control of obesity: Its effect on weight change publication-title: Porto Biomed J – reference: Centers for Disease Control and Prevention. Overweight & Obesity. 2022. (https://www.cdc.gov/obesity/index.html). Accessed July 12, 2023. – volume: 32 start-page: 14 year: 2015 end-page: 20 ident: R20 article-title: The small intestine microbiota, nutritional modulation and relevance for health publication-title: Curr Opin Biotechnol – volume: 55 start-page: 102766 year: 2020 ident: R43 article-title: A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility publication-title: EBioMedicine – volume: 11 start-page: 2194 issue: 9 year: 2009 end-page: 206 ident: R21 article-title: Better living through microbial action: The benefits of the mammalian gastrointestinal microbiota on the host publication-title: Environ Microbiol – volume: 28 start-page: 303 issue: 2 year: 2022 end-page: 14 ident: R34 article-title: Microbiome and metabolome features of the cardiometabolic disease spectrum publication-title: Nat Med – volume: 6 start-page: 944 issue: 12 year: 2018 end-page: 53 ident: R8 article-title: Association of BMI with overall and cause-specific mortality: A population-based cohort study of 3·6 million adults in the UK publication-title: Lancet Diabetes Endocrinol – volume: 32 start-page: 1720 issue: 11 year: 2008 end-page: 4 ident: R18 article-title: Human colonic microbiota associated with diet, obesity and weight loss publication-title: Int J Obes (Lond) – volume: 500 start-page: 541 issue: 7464 year: 2013 end-page: 6 ident: R19 article-title: Richness of human gut microbiome correlates with metabolic markers publication-title: Nature – volume: 8 start-page: 1811 issue: 11 year: 2020 ident: R55 article-title: Duodenal metatranscriptomics to define human and microbial functional alterations associated with severe obesity: A pilot study publication-title: Microorganisms – volume: 10 start-page: e1003531 issue: 4 year: 2014 ident: R31 article-title: Waste not, want not: Why rarefying microbiome data is inadmissible publication-title: PLoS Comput Biol – volume: 19 start-page: 239 issue: 1 year: 2019 ident: R22 article-title: Optimizing microbiome sequencing for small intestinal aspirates: Validation of novel techniques through the REIMAGINE study publication-title: BMC Microbiol – volume: 377 start-page: 13 issue: 1 year: 2017 end-page: 27 ident: R6 article-title: Health effects of overweight and obesity in 195 countries over 25 years publication-title: N Engl J Med – volume: 10 start-page: 188 issue: 1 year: 2022 ident: R46 article-title: Bifidobacterial carbohydrate/nucleoside metabolism enhances oxidative phosphorylation in white adipose tissue to protect against diet-induced obesity publication-title: Microbiome – volume: 34 start-page: 80 issue: 2 year: 2013 end-page: 9 ident: R40 article-title: Effect of Lactobacillus gasseri BNR17 on overweight and obese adults: A randomized, double-blind clinical trial publication-title: Korean J Fam Med – reference: National Cancer Institute. Obesity and Cancer. 2017. (https://www.cancer.gov/about-cancer/causes-prevention/risk/obesity/obesity-fact-sheet). Accessed July 12, 2023. – volume: 9 start-page: 140 issue: 1 year: 2021 ident: R42 article-title: Review: Microbial transformations of human bile acids publication-title: Microbiome – volume: 150 start-page: 155712 year: 2024 ident: R50 article-title: Upper small intestine microbiome in obesity and related metabolic disorders: A new field of investigation publication-title: Metabolism – reference: Centers for Disease Control and Prevention. Adult Obesity Facts. 2020. (https://www.cdc.gov/obesity/data/adult.html). Accessed July 12, 2023. – volume: 4 start-page: 232 issue: 2 year: 2010 ident: R17-20250804 article-title: Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice publication-title: ISME J doi: 10.1038/ismej.2009.112 – volume: 6 start-page: 944 issue: 12 year: 2018 ident: R8-20250804 article-title: Association of BMI with overall and cause-specific mortality: A population-based cohort study of 3·6 million adults in the UK publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(18)30288-2 – volume: 32 start-page: 1720 issue: 11 year: 2008 ident: R18-20250804 article-title: Human colonic microbiota associated with diet, obesity and weight loss publication-title: Int J Obes (Lond) doi: 10.1038/ijo.2008.155 – volume: 32 start-page: 14 year: 2015 ident: R20-20250804 article-title: The small intestine microbiota, nutritional modulation and relevance for health publication-title: Curr Opin Biotechnol doi: 10.1016/j.copbio.2014.09.005 – volume: 12 start-page: 1682 issue: 1 year: 2022 ident: R53-20250804 article-title: Investigating the human jejunal microbiota publication-title: Sci Rep doi: 10.1038/s41598-022-05723-9 – volume: 65 start-page: 2595 issue: 9 year: 2020 ident: R24-20250804 article-title: Mapping the segmental microbiomes in the human small bowel in comparison with stool: A REIMAGINE study publication-title: Dig Dis Sci doi: 10.1007/s10620-020-06173-x – volume: 63 start-page: 101 year: 2019 ident: R11-20250804 article-title: Gut microbiome and type 2 diabetes: Where we are and where to go? publication-title: J Nutr Biochem doi: 10.1016/j.jnutbio.2018.10.003 – volume: 444 start-page: 1027 issue: 7122 year: 2006 ident: R14-20250804 article-title: An obesity-associated gut microbiome with increased capacity for energy harvest publication-title: Nature doi: 10.1038/nature05414 – volume: 2018 start-page: 2037838 year: 2018 ident: R10-20250804 article-title: Gut microbiome dysbiosis and immunometabolism: New frontiers for treatment of metabolic diseases publication-title: Mediators Inflamm doi: 10.1155/2018/2037838 – volume: 29 start-page: 264 issue: 3 year: 2022 ident: R26-20250804 article-title: Duodenal microbiome changes in postmenopausal women: Effects of hormone therapy and implications for cardiovascular risk publication-title: Menopause doi: 10.1097/GME.0000000000001917 – volume: 5 start-page: e9085 year: 2010 ident: R13-20250804 article-title: Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults publication-title: PLoS One doi: 10.1371/journal.pone.0009085 – volume: 9 start-page: 140 issue: 1 year: 2021 ident: R42-20250804 article-title: Review: Microbial transformations of human bile acids publication-title: Microbiome doi: 10.1186/s40168-021-01101-1 – volume: 36 start-page: 109765 issue: 13 year: 2021 ident: R25-20250804 article-title: Age and the aging process significantly alter the small bowel microbiome publication-title: Cell Rep doi: 10.1016/j.celrep.2021.109765 – volume: 9 start-page: 33 issue: 1 year: 2020 ident: R37-20250804 article-title: The structure and function of the human small intestinal microbiota: Current understanding and future directions publication-title: Cell Mol Gastroenterol Hepatol doi: 10.1016/j.jcmgh.2019.07.006 – volume: 66 start-page: e2100639 issue: 3 year: 2022 ident: R47-20250804 article-title: Bifidobacterium animalis subsp. lactis lkm512 attenuates obesity-associated inflammation and insulin resistance through the modification of gut microbiota in high-fat diet-induced obese mice publication-title: Mol Nutr Food Res doi: 10.1002/mnfr.202100639 – volume: 55 start-page: 102766 year: 2020 ident: R43-20250804 article-title: A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility publication-title: EBioMedicine doi: 10.1016/j.ebiom.2020.102766 – volume: 6 start-page: 24 year: 2019 ident: R49-20250804 article-title: Dietary and gut microbiota polyamines in obesity- and age-related diseases publication-title: Front Nutr doi: 10.3389/fnut.2019.00024 – volume: 486 start-page: 207 issue: 7402 year: 2012 ident: R9-20250804 article-title: Structure, function and diversity of the healthy human microbiome publication-title: Nature doi: 10.1038/nature11234 – volume: 39 start-page: 198 issue: 3 year: 2015 ident: R12-20250804 article-title: Gut microbiota and metabolic disorders publication-title: Diabetes Metab J doi: 10.4093/dmj.2015.39.3.198 – volume: 444 start-page: 1022 issue: 7122 year: 2006 ident: R15-20250804 article-title: Microbial ecology: Human gut microbes associated with obesity publication-title: Nature doi: 10.1038/4441022a – volume: 72 start-page: 929 issue: 5 year: 2023 ident: R57-20250804 article-title: Alterations to the duodenal microbiota are linked to gastric emptying and symptoms in functional dyspepsia publication-title: Gut doi: 10.1136/gutjnl-2021-326158 – volume: 376 start-page: 254 issue: 3 year: 2017 ident: R7-20250804 article-title: Mechanisms, pathophysiology, and management of obesity publication-title: N Engl J Med doi: 10.1056/NEJMra1514009 – volume: 150 start-page: 155712 year: 2024 ident: R50-20250804 article-title: Upper small intestine microbiome in obesity and related metabolic disorders: A new field of investigation publication-title: Metabolism doi: 10.1016/j.metabol.2023.155712 – volume: 500 start-page: 541 issue: 7464 year: 2013 ident: R19-20250804 article-title: Richness of human gut microbiome correlates with metabolic markers publication-title: Nature doi: 10.1038/nature12506 – volume: 30 start-page: 279 issue: 2 year: 2023 ident: R48-20250804 article-title: Cell death and inflammation during obesity: “Know my methods, WAT(son)” publication-title: Cell Death Different doi: 10.1038/s41418-022-01062-4 – volume: 10 start-page: e1003531 issue: 4 year: 2014 ident: R31-20250804 article-title: Waste not, want not: Why rarefying microbiome data is inadmissible publication-title: PLoS Comput Biol doi: 10.1371/journal.pcbi.1003531 – volume: 53 start-page: 100 issue: 2 year: 2012 ident: R45-20250804 article-title: Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals publication-title: Microb Pathog doi: 10.1016/j.micpath.2012.05.007 – volume: 9 start-page: 214 issue: 1 year: 2021 ident: R23-20250804 article-title: Quantitative sequencing clarifies the role of disruptor taxa, oral microbiota, and strict anaerobes in the human small-intestine microbiome publication-title: Microbiome doi: 10.1186/s40168-021-01162-2 – volume: 34 start-page: 80 issue: 2 year: 2013 ident: R40-20250804 article-title: Effect of Lactobacillus gasseri BNR17 on overweight and obese adults: A randomized, double-blind clinical trial publication-title: Korean J Fam Med doi: 10.4082/kjfm.2013.34.2.80 – volume: 9 start-page: 369 year: 2020 ident: R54-20250804 article-title: Metagenomic analysis of duodenal microbiota reveals a potential biomarker of dysbiosis in the course of obesity and type 2 diabetes: A pilot study publication-title: J Clin Med doi: 10.3390/jcm9020369 – volume: 11 start-page: 2194 issue: 9 year: 2009 ident: R21-20250804 article-title: Better living through microbial action: The benefits of the mammalian gastrointestinal microbiota on the host publication-title: Environ Microbiol doi: 10.1111/j.1462-2920.2009.01941.x – volume: 5 start-page: 27 issue: 1 year: 2017 ident: R32-20250804 article-title: Normalization and microbial differential abundance strategies depend upon data characteristics publication-title: Microbiome doi: 10.1186/s40168-017-0237-y – volume: 19 start-page: 239 issue: 1 year: 2019 ident: R22-20250804 article-title: Optimizing microbiome sequencing for small intestinal aspirates: Validation of novel techniques through the REIMAGINE study publication-title: BMC Microbiol doi: 10.1186/s12866-019-1617-1 – volume: 13 start-page: 11038 issue: 1 year: 2023 ident: R51-20250804 article-title: Hyperglycemia is associated with duodenal dysbiosis and altered duodenal microenvironment publication-title: Sci Rep doi: 10.1038/s41598-023-37720-x – volume: 12 start-page: e0178868 issue: 6 year: 2017 ident: R35-20250804 article-title: Effect of probiotic Lactobacillus on lipid profile: A systematic review and meta-analysis of randomized, controlled trials publication-title: PLoS One doi: 10.1371/journal.pone.0178868 – volume: 22 start-page: 259 issue: 2 year: 2024 ident: R27-20250804 article-title: Defining small intestinal bacterial overgrowth by culture and high throughput sequencing publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2023.06.001 – volume: 10 start-page: 188 issue: 1 year: 2022 ident: R46-20250804 article-title: Bifidobacterial carbohydrate/nucleoside metabolism enhances oxidative phosphorylation in white adipose tissue to protect against diet-induced obesity publication-title: Microbiome doi: 10.1186/s40168-022-01374-0 – volume: 377 start-page: 13 issue: 1 year: 2017 ident: R6-20250804 article-title: Health effects of overweight and obesity in 195 countries over 25 years publication-title: N Engl J Med doi: 10.1056/NEJMoa1614362 – volume: 28 start-page: 303 issue: 2 year: 2022 ident: R34-20250804 article-title: Microbiome and metabolome features of the cardiometabolic disease spectrum publication-title: Nat Med doi: 10.1038/s41591-022-01688-4 – volume: 18 start-page: 190 issue: 1 year: 2010 ident: R16-20250804 article-title: Microbiota and SCFA in lean and overweight healthy subjects publication-title: Obesity (Silver Spring) doi: 10.1038/oby.2009.167 – volume: 1 start-page: 12 year: 2016 ident: R38-20250804 article-title: Probiotics for the control of obesity: Its effect on weight change publication-title: Porto Biomed J doi: 10.1016/j.pbj.2016.03.005 – volume: 4 start-page: e109 issue: 2 year: 2014 ident: R39-20250804 article-title: Comparative genomics analysis of Lactobacillus species associated with weight gain or weight protection publication-title: Nutr Diabetes doi: 10.1038/nutd.2014.6 – volume: 41 start-page: 1607 issue: 11 year: 2017 ident: R41-20250804 article-title: Effect of Lactobacillus on body weight and body fat in overweight subjects: A systematic review of randomized controlled clinical trials publication-title: Int J Obes doi: 10.1038/ijo.2017.161 – volume: 16 start-page: 1575 issue: 10 year: 2020 ident: R52-20250804 article-title: Mucosa-associated microbiota in the jejunum of patients with morbid obesity: Alterations in states of insulin resistance and metformin treatment publication-title: Surg Obes Relat Dis doi: 10.1016/j.soard.2020.04.008 – volume: 44 start-page: S15 issue: Suppl 1 year: 2021 ident: R28-20250804 article-title: 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes—2021 publication-title: Diabetes Care – volume: 15 start-page: 2172671 issue: 1 year: 2023 ident: R44-20250804 article-title: Bile acids as modulators of gut microbiota composition and function publication-title: Gut Microbes doi: 10.1080/19490976.2023.2172671 – volume: 10 start-page: e0137784 issue: 9 year: 2015 ident: R56-20250804 article-title: A metagenomic investigation of the duodenal microbiota reveals links with obesity publication-title: PLoS One doi: 10.1371/journal.pone.0137784 – volume: 8 start-page: 1811 issue: 11 year: 2020 ident: R55-20250804 article-title: Duodenal metatranscriptomics to define human and microbial functional alterations associated with severe obesity: A pilot study publication-title: Microorganisms doi: 10.3390/microorganisms8111811 – volume: 41 start-page: e1 issue: 1 year: 2013 ident: R30-20250804 article-title: Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies publication-title: Nucleic Acids Res doi: 10.1093/nar/gks808 – volume: 65 start-page: 7f issue: 12 year: 1990 ident: R29-20250804 article-title: At what levels of total low- or high-density lipoprotein cholesterol should diet/drug therapy be initiated? United States guidelines publication-title: Am J Cardiol doi: 10.1016/0002-9149(90)91247-4 – volume: 1 start-page: 6ra14 issue: 6 year: 2009 ident: R33-20250804 article-title: The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice publication-title: Sci Transl Med doi: 10.1126/scitranslmed.3000322 |
SSID | ssj0015275 |
Score | 2.4802973 |
Snippet | INTRODUCTION:Gut microbiome changes are linked to obesity, but findings are based on stool data. In this article, we analyzed the duodenal microbiome and serum... Gut microbiome changes are linked to obesity, but findings are based on stool data. In this article, we analyzed the duodenal microbiome and serum biomarkers... |
SourceID | proquest pubmed crossref wolterskluwer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1141 |
SubjectTerms | Adult Aged Antibiotics Bifidobacterium - isolation & purification Biomarkers - blood Body mass index Diabetes Duodenum - microbiology Female Gastrointestinal Microbiome Gastrointestinal surgery Genomics Glucagon Humans Lactobacillus - isolation & purification Male Metabolism Middle Aged Obesity Obesity - microbiology Overweight Overweight - microbiology Peptides RNA, Ribosomal, 16S - genetics Small intestine Taxonomy Triglycerides Weight control |
Title | Characterization of the Small Bowel Microbiome Reveals Different Profiles in Human Subjects Who Are Overweight or Have Obesity |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&DO=10.14309/ajg.0000000000002790 https://www.ncbi.nlm.nih.gov/pubmed/38578969 https://www.proquest.com/docview/3064097112 https://www.proquest.com/docview/3034249686 |
Volume | 119 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3dT9UwFD9RSIzGGL_AIZKa-DrZ1m5dnwwg5EZykVwl3Ldl61oFLxuyC7zxt3vO2jtRE9zLkm1Nm5329Hc--jsA7wyXuZVxHCaJjkKRl3mYWy5CURl8rtM074nnxwfZ6Eh8mqZT73DrfFrlQif2irpuNfnINwkpE99RnHw4_xlS1SiKrvoSGvdhmajLKKVLTgeDiyq2pgv4qxIZ-RM8gkdqszz95rgL_ZVIUsu396Z_AOcjeHzdUgy7-9GnsN_aiPaewhOPINmWE_kzuGea5_Bg7GPkL-BmZ-BgdkcsWWsZwjz25ayczdh2e21mbHziCJjODJuYKwSLHfvoS6XM2aGr492xk4b1Tn6G6oX8NR07_t5iz4Z97vOpybBn7QUblVf4yJUYeAlHe7tfd0ahr7IQasEp97-0Ii1tLSuJYEBbg0LDna1KtKpjGxtbpjyT0qjSIpjJI11JGymjUq7jrIojvgJLTduYV8BqK4jBTaVGIczSUa55YlSdGWwmua0CEIv_W2hPQU6VMGYFmSIklgLFUvwtlgDeD83OHQfH_xqsL4RX-CXZFb8nUABvh9e4mChCUjamvaRvuEB7NMuzAFad0IceeY7KTWUqgOSPWVC4A6t3j2jt7hG9hocJgiWXgrYOS_OLS_MGwc682uhn9AYsb-1Pjvfxvr17cDj5BRbp-lw |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrcRDCPEmUMBIcAxNbCeODwjRl7a0u1SlFb2FxLGhsE1Ks-2KCz-pv7HjOAkFpHJqjk6cWJnxzDeeF8BLzURiRBj6lKrA50mW-Ilh3Oe5xnEVRUlTeH40joe7_P1etDcHp10ujA2r7GRiI6iLStkz8kWLlG29o5C-Pfzh265R1rvatdBwbLGhf87QZKvfrK8gfV9Rura6szz0264CvuLMxrpnhkeZKUQuUPkpo3GRKMlzqmQRmlCbLGKxEFpmBpV3EqhcmEBqGTEVxnkYMHzvFZjnDE2ZAcwvrY63tnu_RURF1AFuSUXQ5gxxFsjF7NsXVy2xvaiwiuC8NvwH4t6Am7PKes3r703Q_DnVt3YbbrWYlbxzTHYH5nR5F66OWq_8Pfi13Fd9dkmdpDIEgSX5eJBNJmSpmukJGe27kk8HmmzrE4SnNVlpm7NMyZbrHF6T_ZI0bgWCAs2eENXk09cKv6zJhyaC2x4lkOqIDLMTHHJNDe7D7qVQ4AEMyqrUj4AUhtuacTLSEoGdChLFqJZFrHGaYCb3gHf_N1Vt0XPbe2OSWuPHkiVFsqR_k8WD1_20Q1f1438TFjripa0QqNPfLOvBi_42bl_rk8lKXR3bZxhHCzhOYg8eOqL3X2QJilMZSw_oH1yQuhTZi1f0-OIVPYdrw53RZrq5Pt54AtcpQjUXALcAg-nRsX6KUGuaP2v5m8Dny95SZ9X0NWU |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9QwDLfGkCYQQvzbKAwIEjyWa5O0aR4Qgh2nG-PGBEzcW2nTBLbd2rHeduKFD8anw2naMkAaT-tj2jRR7Ng_x44N8EQzkRgRhj6lKvB5kiV-Yhj3ea6xXUVR0iSen2zH413-ZhpNl-BndxfGhlV2MrER1EWl7Bn5wCJlm-8opAPThkXsDEcvjr75toKU9bR25TQci2zp7ws03-rnm0Ok9VNKR68_boz9tsKArzizce-Z4VFmCpELVITKaJwwSvWcKlmEJtQmi1gshJaZQUWeBCoXJpBaRkyFcR4GDP97CS4LFoV2j4lpb-zZarFRB70lFUF7e4izQA6y_S8ub2L7UGFVwlm9-A_YvQrXFpX1n9cHTfj8GSU4ugHXW_RKXjp2uwlLurwFK5PWP38bfmz0-Z_d9U5SGYIQk3w4zGYz8qpa6BmZ7LnkT4eavNenCFRrMmzLtMzJjqshXpO9kjQOBoKizZ4V1eTT1wpH1uRdE8ttDxVIdUzG2Sk2ufIGd2D3QtZ_FZbLqtR3gRSG2-xxMtISIZ4KEsWolkWssZtgJveAd-ubqjb9ua3CMUutGWTJkiJZ0r_J4sGzvtuRy__xvw7rHfHSVhzU6W_m9eBx_xo3svXOZKWuTuw3jKMtHCexB2uO6P2ILEHBKmPpAf2DC1J3Wfb8Gd07f0aPYAU3Uvp2c3vrPlyhiNlcJNw6LM-PT_QDxFzz_GHD3AQ-X_Ru-gUdyjg1 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+of+the+Small+Bowel+Microbiome+Reveals+Different+Profiles+in+Human+Subjects+Who+Are+Overweight+or+Have+Obesity&rft.jtitle=The+American+journal+of+gastroenterology&rft.au=Leite%2C+Gabriela&rft.au=Barlow%2C+Gillian+M&rft.au=Rashid+Mohamad&rft.au=Hosseini+Ava&rft.date=2024-06-01&rft.pub=Wolters+Kluwer+Health+Medical+Research%2C+Lippincott+Williams+%26+Wilkins&rft.issn=0002-9270&rft.eissn=1572-0241&rft.volume=119&rft.issue=6&rft.spage=1141&rft.epage=1153&rft_id=info:doi/10.14309%2Fajg.0000000000002790&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9270&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9270&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9270&client=summon |